Advertisement
Screener

Vir Biotechnology, Inc. (VIR) Net Margin

Vir Biotechnology, Inc. (VIR) Net Margin

  • 2026-06-30: Net Margin 33.51%.
  • 2026-03-31: Net Margin 433431.03%.
  • 2025-12-31: Net Margin -66.99%.
  • 2025-09-30: Net Margin -67975.42%.

Complete source-backed net margin history.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3033.51%
2026-03-31433431.03%
2025-12-31-66.99%
2025-09-30-67975.42%
2025-06-30-9139.87%
2025-03-31-3989.61%
2024-12-31-845.23%
2024-09-30-8979.71%
2024-06-30-4500.10%
2024-03-31-115.79%
2023-12-31-690.85%
2023-09-30-6192.23%
2023-06-30-5129.71%
2023-03-31-223.89%
2022-12-31-205.63%
2022-09-3046.81%
2022-06-30188.27%
2022-03-3142.08%
2021-12-3164.63%
2021-09-30106.57%
2021-06-3034.91%
2021-03-31-8548.13%
2020-12-31-6092.79%
2020-09-30-4388.43%
2020-06-30-46.53%
2020-03-31-1350.82%
2019-12-31-6507.24%
2019-09-30-3443.62%
2019-06-30-1657.45%
2019-03-31-783.12%
2018-12-31-844.31%
2018-09-30-1159.65%

Annual Net Margin

DateNet Margin
2025-12-31-638.87%
2024-12-31-703.40%
2023-12-31-713.69%
2022-12-3131.92%
2021-12-3148.25%
2020-12-31-391.09%
2019-12-31-2158.98%
2018-12-31-1086.28%
2017-12-31-2579.47%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Vericel Corp (VCEL)United States$2.011B93.97
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40